Drug Profile
Research programme: anti-infectives - Ampika
Latest Information Update: 28 Sep 2020
Price :
$50
*
At a glance
- Originator Ampika
- Class Anti-infectives
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes
Highest Development Phases
- No development reported Malaria; Mycoses; Viral infections
Most Recent Events
- 28 Sep 2020 No recent reports of development identified for research development in Malaria in United Kingdom
- 28 Sep 2020 No recent reports of development identified for research development in Mycoses in United Kingdom
- 28 Sep 2020 No recent reports of development identified for research development in Viral-infections in United Kingdom